DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Firms / Quaker Partners Management L.P.
Quaker Partners Management L.P.
venture manager, reported GAV $7.0M across 1 vehicles
Importance
11
low
Active deployment
0
low
Emerging
0
low
Completeness
50
elevated
Freshness
100
high
Research priority
3
low
Identity and regulatory footprint
- Headquarters
- Bala Cynwyd, PAadviserinfo.sec.gov
- Office address
- 150 MONUMENT ROAD, SUITE 207, Bala Cynwyd, PA, 19004adviserinfo.sec.gov
- Business phone
- 267-288-8441adviserinfo.sec.gov
- Website
- HTTP://WWW.QUAKERBIO.COM
- SEC adviser type
- exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- unknown
- Latest Form ADV
- Jan 11, 2024
- Private funds reported
- 1 (1 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $7.0Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- Owners on Schedule A
- Quaker Bioventures Management, LLC (General Partner), NA
- business phone
- 267-288-8441adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
no observed deals yet
Stated (the firm’s website)
- Sectors
- not stated or not yet read
- Stages
- not stated or not yet read
- Geography
- not stated
- Check size
- not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors: no observed deals yet
lead rate n/afollow-on rate n/anew logos, 12 months 0
Funds and vehicles
1 reported, 4 no longer reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| Quaker Bioventures II, L.P. | Fund | unknown | Unknown | $7.0M Jan 11, 2024 | 37 | unknown | unknown |
| Garden State Life Sciences Venture Fund, L.P. | Fund | unknown | Wound down | $1.3M Apr 4, 2016 | 2 | unknown | unknown |
| Quaker Bioventures, L.P. | Fund | unknown | Wound down | $1.1M Mar 30, 2020 | 66 | unknown | unknown |
| Quaker Bioadvance Ventures, L.P. | Fund | unknown | Wound down | $287,357 Mar 30, 2020 | 22 | unknown | unknown |
| Quaker Bioventures Tobacco Fund, L.P. | Fund | unknown | Wound down | $136,543 Mar 30, 2020 | 2 | unknown | unknown |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
9 current, 1 departed
Adele Cirone Oliva
PartnerMember · since Jan 1, 2011
Howard David Ross
PartnerLimited Partner · since Feb 1, 2003
IRA Mark Lubert
PartnerMember · since Feb 1, 2003
Mitchell Louis Hollin
PartnerLimited Partner · since Feb 1, 2003
Paul Sherrill Neff
PartnerMember · since Feb 1, 2003
Richard Scott Kollender
PartnerMember · since Jan 1, 2011
Seth Jonathan Lehr
PartnerLimited Partner · since Feb 1, 2003
Brian Richard Schwenk
Platform and operationsChief Financial Officer · since Jun 1, 2015
Michelle Woods Vaughn
Platform and operationsChief Compliance Officer · since Aug 1, 2012
1 departed (kept with end dates)
- Vincent Paul Mcdevitt · Chief Compliance Officer · Mar 1, 2012 to Aug 29, 2012 Inference
Investments on record
0 edges, 0 companies, 0 partner-attributed
No investment on record yet. Edges arrive from the firm’s portfolio page, financing announcements, and Form D board seats.
Co-investors
0 relationships from shared deals, counted for the whole firm
No co-investor relationship yet: these are derived only from rounds and portfolio listings the graph has seen both investors on.
Limited partners
1 disclosed
Timeline
13 dated events
- Mar 25, 2021Quaker Bioventures Tobacco Fund, L.P. no longer reported on Form ADV by Quaker Partners Management L.P.Fund no longer reportedFundsInferenceQuaker Bioventures Tobacco Fund, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 25, 2021Quaker Bioventures, L.P. no longer reported on Form ADV by Quaker Partners Management L.P.Fund no longer reportedFundsInferenceQuaker Bioventures, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 25, 2021Quaker Bioadvance Ventures, L.P. no longer reported on Form ADV by Quaker Partners Management L.P.Fund no longer reportedFundsInferenceQuaker Bioadvance Ventures, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 23, 2017Garden State Life Sciences Venture Fund, L.P. no longer reported on Form ADV by Quaker Partners Management L.P.Fund no longer reportedFundsInferenceGarden State Life Sciences Venture Fund, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Jun 1, 2015Brian Richard Schwenk joined Schedule A of Quaker Partners Management L.P. as Chief Financial Officer
- Aug 29, 2012Vincent Paul Mcdevitt (Chief Compliance Officer) no longer on Schedule A of Quaker Partners Management L.P.
- Aug 1, 2012Michelle Woods Vaughn joined Schedule A of Quaker Partners Management L.P. as Chief Compliance Officer
- Mar 29, 2012Quaker Bioventures II, L.P. first reported on Form ADV by Quaker Partners Management L.P. (Venture Capital Fund), GAV $153,728,314Fund first reported on Form ADVFundsFactQuaker Bioventures II, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 29, 2012Quaker Partners Management L.P. first filed Form ADV (ERA, venture capital fund adviser exemption)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 29, 2012Quaker Bioadvance Ventures, L.P. first reported on Form ADV by Quaker Partners Management L.P. (Venture Capital Fund), GAV $12,394,606Fund first reported on Form ADVFundsFactQuaker Bioadvance Ventures, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 29, 2012Quaker Bioventures Tobacco Fund, L.P. first reported on Form ADV by Quaker Partners Management L.P. (Venture Capital Fund), GAV $12,119,497Fund first reported on Form ADVFundsFactQuaker Bioventures Tobacco Fund, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 29, 2012Quaker Bioventures, L.P. first reported on Form ADV by Quaker Partners Management L.P. (Venture Capital Fund), GAV $75,981,154Fund first reported on Form ADVFundsFactQuaker Bioventures, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 29, 2012Garden State Life Sciences Venture Fund, L.P. first reported on Form ADV by Quaker Partners Management L.P. (Venture Capital Fund), GAV $7,250,131Fund first reported on Form ADVFundsFactGarden State Life Sciences Venture Fund, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
- Sep 12, 2026Micro VC (probable, 80%, cls-1)venture manager, reported GAV $7.0M across 1 vehicles
Evidence
30 observations from 2 sources